AC
Live price temporarily unavailable.
Price history
Actuate Therapeutics Inc (ACTU) is a Health Care company. Latest news and coverage below.
IPO: August 13, 2024 · $8.00 offering · NASDAQ · View IPO details →
Actuate Therapeutics Inc net income history (FY2023–FY2025)
Net income
| FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|
| Income statement | |||
| Operating income | −$25.0M | −$25.2M | −$22.5M |
| Net income | −$24.7M | −$27.3M | −$22.2M |
| EPS (diluted) | −$17.24 | −$3.26 | −$1.06 |
| Balance sheet | |||
| Cash and equivalents | $2.96M | $8.64M | $13.2M |
| Total assets | $3.00M | $9.32M | $14.0M |
| Total liabilities | $8.44M | $9.21M | $6.11M |
| Shareholders' equity | −$99.6M | $104.2K | $7.92M |
| Cash flow | |||
| Operating cash flow | −$21.6M | −$21.8M | −$19.2M |
Net income
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$5.39M | −$6.56M | −$6.37M | −$5.97M | −$5.47M | −$4.69M | −$5.71M | −$4.91M |
| Net income | −$5.97M | −$6.45M | −$6.32M | −$5.95M | −$5.41M | −$4.55M | −$5.63M | −$4.87M |
| EPS (diluted) | −$0.55 | $6.89 | −$0.32 | −$0.30 | −$0.25 | −$0.19 | −$0.24 | −$0.20 |
| Balance sheet | ||||||||
| Cash and equivalents | $13.5M | $8.64M | $3.89M | $6.49M | $16.9M | $13.2M | $8.13M | $4.43M |
| Total assets | $14.3M | $9.32M | $4.48M | $6.97M | $17.7M | $14.0M | $8.91M | $5.20M |
| Total liabilities | $8.90M | $9.21M | $9.57M | $9.62M | $6.78M | $6.11M | $5.13M | $4.21M |
| Shareholders' equity | $5.36M | $104.2K | −$5.09M | −$2.65M | $10.9M | $7.92M | $3.78M | $989.2K |
| Cash flow | ||||||||
| Operating cash flow | −$9.15M | −$4.77M | −$4.62M | −$4.17M | −$6.68M | −$3.74M | −$5.02M | −$4.41M |
From Actuate Therapeutics Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Actuate Therapeutics Inc
- Headquarters
- Fort Worth, Texas From SEC filings, Oct 2026
Recent News (1)
More Health Care stocks
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- ALNY Alnylam Pharmaceuticals
- AMGN Amgen
- BAX Baxter International